Dear ADITEC Partner and Associates, We wish you and your families a Merry Christmas and a very Happy New Year. We take the opportunity to…
The ADITEC Project on Advanced Immunization Technologies: an European Success Story. 30 million Euros of funding, 42 public and private institutions have joined forces for…
The European Parliament holds an event on “Vaccine Research and Development in Europe” highlighting the ADITEC success story The Science and Technology Options Assessment (STOA)…
The ADITEC Project on Advanced Immunization Technologies: an European Success Story. 30 million Euros of funding, 42 public and private institutions have joined forces for…
A shot in the arm for vaccine research Published by the European Commission and features on their website The European Commission highlights the ADITEC project as…
Call for EC Funded Commissioned Research for SMEs and Public Health Organizations Support for Vaccine Development Deadline: Friday 6 May 2016 5:00 p.m. CET Commissioned…
Support for Vaccine Development Deadline: Friday 6 May 2016 5:00 p.m. CET The High Impact project on Advanced Immunization Technologies (ADITEC), funded through the 7th…
Siena/Brussels – 23 November 2015 – High quality vaccine research funded by the EUR 30 million FP7 High Impact Project on Advanced Immunization Technologies (ADITEC)…
Support for Vaccine Development Deadline: 30 October 2015 5:00 p.m. CET Anticipated Decision Date 30 November 2015 The High Impact project on Advanced Immunization Technologies…
Adjuvanted trivalent influenza vaccine study in infants: A randomised controlled trial to determine the kinetics of the functional genomic response In the 2012 influenza season, ADITEC…